The federal government's officials now wield such extraordinary power over PBS decision-making that the time has come for the pharmaceutical industry and other stakeholders to make the case for external oversight.
More power in the hands of officials means the time has come for external oversight
August 26, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
ACT unveils plan to close New Zealand’s medicines gap by 2033
July 26, 2026 - - Latest News -
The 'Dispatched' Podcast - Series 5, Ep.25
July 24, 2026 - - Podcast -
Finalists named for the 2026 Patient's Choice awards
July 24, 2026 - - Latest News -
The 'end of days' language is just a farcical attempt to shut down discussion
July 24, 2026 - - Latest News -
Australian company moving headquarters to US and restructuring workforce
July 24, 2026 - - Latest News -
Faster processes could push Pharmac's options for investment backlog to 400 within two years
July 23, 2026 - - Latest News -
Bellberry and ASCEPT release checklist for 'new approach methodologies' trials
July 23, 2026 - - Latest News

